Litigation Details for UCB, Inc. v. Hetero USA Inc. (D. Del. 2016)
✉ Email this page to a colleague
UCB, Inc. v. Hetero USA Inc. (D. Del. 2016)
| Docket | ⤷ Sign Up | Date Filed | 2016-06-17 |
| Court | District Court, D. Delaware | Date Terminated | 2018-09-20 |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | None | Referred To | |
| Patents | RE38,551 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in UCB, Inc. v. Hetero USA Inc.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for UCB, Inc. v. Hetero USA Inc. (D. Del. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2016-06-17 | 1 | A)(vii)(IV) with respect to U.S. Reissue Patent No. RE38,551” because it was “no longer seeking FDA approval…action for patent infringement of United States Reissued Patent No. RE 38,551 (“the ʼ551 patent”), arising…Extending Patent Term Under 35 U.S.C. § 156. With the patent term extension, the ʼ551 patent expires on…The United States Patent and Trademark Office (“PTO”) legally issued the ʼ551 patent, entitled “Anticonvulsant…copy of the ’551 patent is attached as Exhibit A. 17. The ’551 patent is a reissue of | External link to document | |
| 2018-09-14 | 26 | 1206-LPS (the “Accord Action”), that U.S. Patent No. RE38,551 is infringed and not invalid (D.I. 323 in… 9, 10, and 13 of U.S. Reissued Patent No. RE 38,551 (the “’551 Patent”). 2. Judgment is …the date of expiration of the ’551 Patent inclusive of the patent term extension granted under 35 U.S.C…Hetero”) stipulated to infringement of the ’551 Patent (D.I. 196 in the Accord Action), WHEREAS… invalidity of claims 9, 10, and 13 of the ’551 Patent. 3. Pursuant to 35 U.S.C. § 271(e) | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
